Diagnostics

Gene Identification More Reliable for Detecting Micrometastasis in Lymph Nodes

Published in Cancer Weekly, January 30th, 2001

Though laboratory testing for markers such as cytokeratin are used in the analysis of tumors and tissues samples where metastasis is suspected, those tests are not always sensitive enough to distinguish cellular identifiers that occur in both normal and cancerous cells.

A new study reported in Cancer Research proposes that testing with a gene amplification method is a better way to identify micrometastasis, particularly within the lymph nodes of non-small cell lung cancer patients.

The method referred to by authors of the new study is called mutant allele-specific amplification (MASA). "MASA can detect DNAs derived from cancer cells itself,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-01-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry